Compare LMNR & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMNR | ARCT |
|---|---|---|
| Founded | 1893 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.9M | 245.4M |
| IPO Year | 2005 | 2019 |
| Metric | LMNR | ARCT |
|---|---|---|
| Price | $12.69 | $7.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 10 |
| Target Price | $20.00 | ★ $24.11 |
| AVG Volume (30 Days) | 53.7K | ★ 412.3K |
| Earning Date | 06-08-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.37% | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $159,723,000.00 | $82,031,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.95 | $12.77 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.20 | $5.85 |
| 52 Week High | $17.11 | $24.14 |
| Indicator | LMNR | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 43.03 | 39.78 |
| Support Level | $12.54 | $6.90 |
| Resistance Level | $14.86 | $7.88 |
| Average True Range (ATR) | 0.36 | 0.59 |
| MACD | -0.01 | -0.17 |
| Stochastic Oscillator | 2.53 | 18.01 |
Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.